Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Frey

Showing results (21-30 of 41) with videos related to

Pageof 5
Sort By:
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|April 23, 2019
Comorbid hypertension in patients with major depressive disorder - Results from a European multicenter studyGernot Fugger, Markus Dold, Lucie Bartova, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|May 6, 2019
Major Depression and Comorbid Diabetes - Findings from the European Group for the Study of Resistant DepressionGernot Fugger, Markus Dold, Lucie Bartova, et al.
Analytical and Bioanalytical Chemistry|February 27, 2025
Integrating the lactulose-mannitol test for intestinal permeability with untargeted metabolomics for drug monitoring through dual liquid chromatography-mass spectrometryFelina Hildebrand, Cemre Cukaci, Harald Schoeny, et al.
Neuroimage|May 15, 2012
Combining image-derived and venous input functions enables quantification of serotonin-1A receptors with [carbonyl-11C]WAY-100635 independent of arterial samplingAndreas Hahn, Lukas Nics, Pia Baldinger, et al.
Brain Stimulation|April 20, 2019
Acute and subsequent continuation electroconvulsive therapy elevates serum BDNF levels in patients with major depressionThomas Vanicek, Georg S Kranz, Benjamin Vyssoki, et al.
The International Journal of Neuropsychopharmacology|September 5, 2020
Clinical Correlates and Outcome of Major Depressive Disorder and Comorbid Migraine: A Report of the European Group for the Study of Resistant DepressionGernot Fugger, Markus Dold, Lucie Bartova, et al.
The British Journal of Psychiatry : the Journal of Mental Science|November 17, 2018
Structural changes in amygdala nuclei, hippocampal subfields and cortical thickness following electroconvulsive therapy in treatment-resistant depression: longitudinal analysisGregor Gryglewski, Pia Baldinger-Melich, René Seiger, et al.
Frontiers in Psychiatry|August 14, 2023
Case report: Hyperactive delirium after a single dose of zolpidem administered additionally to psychopharmacotherapy including clozapineMaximilian Preiss, Ulrich Rabl, Valentin Popper, et al.
Journal of Psychiatric Research|February 24, 2005
White matter hyperintensities and chronicity of depressionAngela Heiden, Joachim Kettenbach, Peter Fischer, et al.
Scientific Reports|July 2, 2025
Brain glutamate and gamma-aminobutyric acid levels across COVID-19 lockdowns in patients with recurrent major depressive disorder and healthy individualsValentin Popper, Benjamin Spurny-Dworak, Jakob Unterholzner, et al.
Pageof 5

Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|April 23, 2019
Comorbid hypertension in patients with major depressive disorder - Results from a European multicenter studyGernot Fugger, Markus Dold, Lucie Bartova, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|May 6, 2019
Major Depression and Comorbid Diabetes - Findings from the European Group for the Study of Resistant DepressionGernot Fugger, Markus Dold, Lucie Bartova, et al.
Analytical and Bioanalytical Chemistry|February 27, 2025
Integrating the lactulose-mannitol test for intestinal permeability with untargeted metabolomics for drug monitoring through dual liquid chromatography-mass spectrometryFelina Hildebrand, Cemre Cukaci, Harald Schoeny, et al.
Neuroimage|May 15, 2012
Combining image-derived and venous input functions enables quantification of serotonin-1A receptors with [carbonyl-11C]WAY-100635 independent of arterial samplingAndreas Hahn, Lukas Nics, Pia Baldinger, et al.
Brain Stimulation|April 20, 2019
Acute and subsequent continuation electroconvulsive therapy elevates serum BDNF levels in patients with major depressionThomas Vanicek, Georg S Kranz, Benjamin Vyssoki, et al.
The International Journal of Neuropsychopharmacology|September 5, 2020
Clinical Correlates and Outcome of Major Depressive Disorder and Comorbid Migraine: A Report of the European Group for the Study of Resistant DepressionGernot Fugger, Markus Dold, Lucie Bartova, et al.
The British Journal of Psychiatry : the Journal of Mental Science|November 17, 2018
Structural changes in amygdala nuclei, hippocampal subfields and cortical thickness following electroconvulsive therapy in treatment-resistant depression: longitudinal analysisGregor Gryglewski, Pia Baldinger-Melich, René Seiger, et al.
Frontiers in Psychiatry|August 14, 2023
Case report: Hyperactive delirium after a single dose of zolpidem administered additionally to psychopharmacotherapy including clozapineMaximilian Preiss, Ulrich Rabl, Valentin Popper, et al.
Journal of Psychiatric Research|February 24, 2005
White matter hyperintensities and chronicity of depressionAngela Heiden, Joachim Kettenbach, Peter Fischer, et al.
Scientific Reports|July 2, 2025
Brain glutamate and gamma-aminobutyric acid levels across COVID-19 lockdowns in patients with recurrent major depressive disorder and healthy individualsValentin Popper, Benjamin Spurny-Dworak, Jakob Unterholzner, et al.
Pageof 5